Selected article for: "case control and control case"

Author: Ria Lassaunière; Anders Frische; Zitta B Harboe; Alex CY Nielsen; Anders Fomsgaard; Karen A Krogfelt; Charlotte S Jørgensen
Title: Evaluation of nine commercial SARS-CoV-2 immunoassays
  • Document date: 2020_4_10
  • ID: 8cg5yj20_13
    Snippet: The distance of data points from the manufacturer recommended cut-off values and confidence in assigning a positive or negative status differed between the three assays ( Figure 1A ). The distribution of positive and negative data points were distinct for the Wantai Total Ab assay, with a cut-off value above all the control sera samples, which allowed for unequivocal interpretation. Conversely, the Euroimmun IgA and IgG assays data had a less dis.....
    Document: The distance of data points from the manufacturer recommended cut-off values and confidence in assigning a positive or negative status differed between the three assays ( Figure 1A ). The distribution of positive and negative data points were distinct for the Wantai Total Ab assay, with a cut-off value above all the control sera samples, which allowed for unequivocal interpretation. Conversely, the Euroimmun IgA and IgG assays data had a less distinct separation, resulting in a 'grey zone' of borderline data points to which a positive or negative status could not be assigned. Both case and control sera had borderline or inconclusive data points.

    Search related documents:
    Co phrase search for related documents
    • control sera and cut value: 1, 2